Protagenic Therapeutics, Inc.\new (PTIX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K/A	10-K/A
Total revenues [+]	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.0
Royalties							0.4
Revenue growth					-100.0%	469.4%		-100.0%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	2.4	-0.4	0.0
Gross margin						100.0%	-100.0%
Selling, general and administrative [+]	2.0	3.0	1.9	1.3	1.4	1.6	1.4	0.6
General and administrative [+]	2.0	3.0	1.9	1.3	1.4	1.6	1.4	0.6
General and administrative expenses	2.0	3.0	1.9	1.3	1.4	1.6	1.4	0.6
Other selling, general and administrative
Research and development	1.6	1.1	0.7	0.8	0.9	0.7		0.5
Other operating expenses				-0.3	0.3	2.3
EBITDA [+]	-3.6		-2.6	-1.7	-2.6	-2.3	-1.8	-1.0
EBITDA growth	-14.1%	62.3%	46.5%	-32.1%	12.7%	24.4%	78.4%	251.3%
EBITDA margin						-95.6%	-437.7%
Depreciation and amortization	0.0		0.0	0.0	0.0	0.0	0.0	0.0
EBIT [+]	-3.6	-4.1	-2.6	-1.7	-2.6	-2.3	-1.8	-1.0
EBIT growth	-14.1%	62.3%	46.5%	-32.1%	12.8%	24.3%	78.5%	250.9%
EBIT margin						-95.6%	-437.8%
Non-recurring items [+]				0.3	-0.3	0.1	0.4
Asset impairment							0.4
Interest expense, net [+]	0.0	0.5	0.2					0.0
Interest expense	0.1	0.5	0.2					0.0
Interest income	0.2	0.0	0.0
Other income (expense), net [+]	0.0	0.1	0.2	0.3	-0.2	0.1	0.0	0.0
Realized gain (loss) on investments				0.0	0.0	0.0
Gain (loss) on derivative instruments		0.1	0.2	0.3	-0.3	0.1
Unrealized gain/loss on derivatives							0.0
Gain (loss) on foreign currency transactions								0.0
Other non-operating income				0.0	0.0
Other non-ooperating expenses				0.0
Other				0.0	0.0	0.0
Pre-tax income	-3.6	-4.5	-2.5	-1.8	-2.6	-2.3	-2.3	-1.0
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-3.6	-4.5	-2.5	-1.8	-2.6	-2.3	-2.3	-1.0
Net margin						-95.0%	-544.6%

Basic EPS [+]	($0.82)	($1.23)	($0.25)	($0.17)	($0.25)	($0.22)	($0.43)	($0.15)
Growth	-32.9%	397.9%	44.5%	-31.5%	13.2%	-48.7%	177.2%	238.3%
Diluted EPS [+]	($0.82)	($1.23)	($0.25)	($0.17)	($0.25)	($0.22)	($0.43)	($0.15)
Growth	-32.9%	397.9%	44.5%	-31.5%	13.2%	-48.7%	177.2%	238.3%

Shares outstanding (basic) [+]	4.3	3.7	10.3	10.3	10.3	10.3	5.3	6.6
Growth	17.2%	-64.4%	0.8%	0.0%	0.0%	93.4%	-19.8%	0.0%
Shares outstanding (diluted) [+]	4.3	3.7	10.3	10.3	10.3	10.3	5.3	6.6
Growth	17.2%	-64.4%	0.8%	0.0%	0.0%	93.4%	-19.8%	0.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.